相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Annett Hessel et al.
PLOS ONE (2014)
Stability of neuraminidase in inactivated influenza vaccines
Ishrat Sultana et al.
VACCINE (2014)
AAV vectors vaccines against infectious diseases
Karen Nieto et al.
FRONTIERS IN IMMUNOLOGY (2014)
New vaccines against influenza virus
Young-Tae Lee et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2014)
Toward a Universal Influenza Virus Vaccine: Prospects and Challenges
Natalie Pica et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Broadly neutralizing antibodies against influenza viruses
Nick S. Laursen et al.
ANTIVIRAL RESEARCH (2013)
Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses
Alaina J. Mooney et al.
FUTURE VIROLOGY (2013)
Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
Robert B. Couch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Recombinant Parainfluenza Virus 5 Expressing Hemagglutinin of Influenza A Virus H5N1 Protected Mice against Lethal Highly Pathogenic Avian Influenza Virus H5N1 Challenge
Zhuo Li et al.
JOURNAL OF VIROLOGY (2013)
Recombinant Parainfluenza Virus 5 Vaccine Encoding the Influenza Virus Hemagglutinin Protects against H5N1 Highly Pathogenic Avian Influenza Virus Infection following Intranasal or Intramuscular Vaccination of BALB/c Mice
Alaina J. Mooney et al.
JOURNAL OF VIROLOGY (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
Single-Dose Vaccination of a Recombinant Parainfluenza Virus 5 Expressing NP from H5N1 Virus Provides Broad Immunity against Influenza A Viruses
Zhuo Li et al.
JOURNAL OF VIROLOGY (2013)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness
Sai V. Vemula et al.
PLOS ONE (2013)
Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
Eric A. Weaver et al.
PLOS ONE (2013)
Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
Maria P. Limberis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
Asisa Volz et al.
VACCINE (2013)
Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge
Mookkan Prabakaran et al.
VACCINE (2013)
Utilizing poxviral vectored vaccines for antibody induction-Progress and prospects
Simon J. Draper et al.
VACCINE (2013)
Influenza Vaccines: Unmet Needs and Recent Developments
Ji Yun Noh et al.
INFECTION AND CHEMOTHERAPY (2013)
Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans
Patrick J. Lillie et al.
CLINICAL INFECTIOUS DISEASES (2012)
Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
Ann Duerr et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin
Jeff Alexander et al.
PLOS ONE (2012)
Protective Efficacy of Newcastle Disease Virus Expressing Soluble Trimeric Hemagglutinin against Highly Pathogenic H5N1 Influenza in Chickens and Mice
Lisette A. H. M. Cornelissen et al.
PLOS ONE (2012)
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
Richard D. Antrobus et al.
PLOS ONE (2012)
Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5
Zhenhai Chen et al.
PLOS ONE (2012)
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines
Robert B. Couch et al.
VACCINE (2012)
Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
Jianfeng Zhang
VIRUSES-BASEL (2012)
Correlates of vaccine protection from influenza and its complications
Jonathan A. McCullers et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine
Qunfeng Wu et al.
ANTIVIRAL RESEARCH (2011)
Coexpression of Avian Influenza Virus H5 and N1 by Recombinant Newcastle Disease Virus and the Impact on Immune Response in Chickens
Kristina Ramp et al.
AVIAN DISEASES (2011)
Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
The STEP Study Provides a Hint That Vaccine Induction of the Right CD8+ T Cell Responses Can Facilitate Immune Control of HIV
Marcus Altfeld et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus
Timothy Sheahan et al.
JOURNAL OF VIROLOGY (2011)
Vesicular Stomatitis Virus-Based H5N1 Avian Influenza Vaccines Induce Potent Cross-Clade Neutralizing Antibodies in Rhesus Macaques
Jennifer A. Schwartz et al.
JOURNAL OF VIROLOGY (2011)
Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice
Mark R. Soboleski et al.
PLOS ONE (2011)
Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice
Mookkan Prabakaran et al.
ANTIVIRAL RESEARCH (2010)
Production of adenovirus vectors and their use as a delivery system for influenza vaccines
Sai V. Vemula et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Cross-protective immunity to influenza A viruses
Suzanne L. Epstein et al.
EXPERT REVIEW OF VACCINES (2010)
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
Michael A. Morse et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys
Joshua M. DiNapoli et al.
JOURNAL OF VIROLOGY (2010)
Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge
Jennifer A. Schwartz et al.
JOURNAL OF VIROLOGY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret
Srinivas S. Rao et al.
PLOS ONE (2010)
A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model
Ami Patel et al.
PLOS ONE (2010)
A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses
Arash Hassantoufighi et al.
VACCINE (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Bench-to-bedside review: Vaccine protection strategies during pandemic flu outbreaks
Joel V. Chua et al.
CRITICAL CARE (2010)
A New Genetic Vaccine Platform Based on an Adeno-Associated Virus Isolated from a Rhesus Macaque
Jianping Lin et al.
JOURNAL OF VIROLOGY (2009)
A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens
Qunfeng Wu et al.
MOLECULAR IMMUNOLOGY (2009)
Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses
Baibaswata Nayak et al.
PLOS ONE (2009)
Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs
Constantinos S. Kyriakis et al.
VACCINE (2009)
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
Graeme E. Price et al.
VACCINE (2009)
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
David I. Bernstein et al.
VACCINE (2009)
Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
Julie Delaloye et al.
PLOS PATHOGENS (2009)
Gene Therapy Using Adeno-Associated Virus Vectors
Shyam Daya et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax
Claire M. Midgley et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Differential CD4(+) versus CD8(+) T-cell responses elicited by different poxvirus-based human immunodeficiency virus type I vaccine candidates provide comparable efficacies in primates
Petra Mooij et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
Max Corbett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant
Mookkan Prabakaran et al.
VIROLOGY (2008)
Immunization of primates with a newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus
Joshua M. DiNapoli et al.
JOURNAL OF VIROLOGY (2007)
Vesicular stomatitis virus vectors expressing avian influenza H5HA induce cross-neutralizing antibodies and long-term protection
Jennifer A. Schwartz et al.
VIROLOGY (2007)
Current status of veterinary vaccines
Els N. T. Meeusen et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge
S. Mark Tompkins et al.
VIROLOGY (2007)
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
J. Erik Johnson et al.
VIROLOGY (2007)
Vaccine delivery methods using viral vectors
Andreas Brave et al.
MOLECULAR PHARMACEUTICS (2007)
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
Stephen Mark Tompkins et al.
EMERGING INFECTIOUS DISEASES (2007)
Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses
Jinying Ge et al.
JOURNAL OF VIROLOGY (2007)
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene
Jos Luis Najera et al.
JOURNAL OF VIROLOGY (2006)
Engineered viral vaccine constructs with dual specificity:: Avian influenza and Newcastle disease
Man-Seong Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza
Jutta Veits et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mucosal and systemic adjuvant activity of alphavirus replicon particles
JM Thompson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Development of nonhuman adenoviruses as vaccine vectors
DS Bangari et al.
VACCINE (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Purification of adenovirus and adeno-associated virus: Comparison of novel membrane-based technology to conventional techniques
AM Duffy et al.
GENE THERAPY (2005)
The unmet need in the elderly: Designing new influenza vaccines for older adults
JE McElhaney
VACCINE (2005)
Recombinant viruses as vaccines against viral diseases
APD Souza et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Vesicular stomatitis virus: re-inventing the bullet
BD Lichty et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Pneumonia in the elderly
M Loeb
CURRENT OPINION IN INFECTIOUS DISEASES (2004)
Influenza-associated hospitalizations in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus
RD Wesley et al.
VACCINE (2004)
Current status of live attenuated influenza virus vaccine in the US
RB Belshe
VIRUS RESEARCH (2004)
Equine viral vaccines: the past, present and future
JM Minke et al.
VETERINARY RESEARCH (2004)
Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice
T Abe et al.
JOURNAL OF IMMUNOLOGY (2003)
Recombinant Newcastle disease virus as a vaccine vector
Z Huang et al.
POULTRY SCIENCE (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease
DE Swayne et al.
AVIAN DISEASES (2003)
Adenovirus and adeno-associated virus vectors
CM Lai et al.
DNA AND CELL BIOLOGY (2002)
Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/I/68 (H3N2)
M Tang et al.
ARCHIVES OF VIROLOGY (2002)
Alphavirus vectors and vaccination
JO Rayner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Recombinant baculoviruses as mammalian cell gene-delivery vectors
TA Kost et al.
TRENDS IN BIOTECHNOLOGY (2002)
Recombinant Newcastle disease virus as a vaccine vector
T Nakaya et al.
JOURNAL OF VIROLOGY (2001)
Live attenuated influenza virus vaccines: new options for the prevention of influenza
KL Nichol
VACCINE (2001)
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
KQ Xin et al.
HUMAN GENE THERAPY (2001)
Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses
S Schultz-Cherry et al.
VIROLOGY (2000)
分享论文
